Melasma Treatment Options: From OTC Routine to Dermatology

The short answer

Melasma is hormone- and UV-driven hyperpigmentation. The OTC routine that addresses it: iron-oxide-tinted broad-spectrum sunscreen ^[C11] + vitamin C antioxidant + tranexamic acid 2–5% + azelaic acid 10%. For severe or stubborn cases, dermatology evaluation for hydroquinone, prescription combinations, or in-office procedures.

What melasma is

Melasma is symmetric facial hyperpigmentation, most often on cheeks, forehead, upper lip, and chin. It's driven by a combination of UV exposure (including visible light, not just UVB/UVA), hormonal influence (pregnancy, oral contraceptives, hormone replacement therapy), and individual susceptibility. Skin tones with more melanin are at higher risk for visible melasma.

The pigmentation lives in two depths: epidermal (the more responsive form) and dermal (the resistant form). Mixed-type melasma involves both. The depth determines treatment responsiveness — epidermal melasma fades faster; dermal melasma needs longer, multi-modal treatment.

The OTC routine

Layer 1 — UV protection (load-bearing):

• Broad-spectrum SPF 50+ daily, every 2 hours during sun exposure
• Iron-oxide tinted formulations specifically — they block visible light and short-wavelength HEV that contribute to melasma per ^[C11] and ^[G9]
• Hat and shade in addition to sunscreen — UV protection is the single biggest predictor of melasma outcomes

Layer 2 — Pigment-pathway interruption:

• Vitamin C AM (10–20% L-ascorbic acid at pH below 3.5, or vitamin C derivative for sensitive skin)
• Tranexamic acid 2–5% PM
• Azelaic acid 10% twice daily — covers a different mechanism (tyrosinase inhibition + anti-inflammatory action)
• Niacinamide 4–5% daily — blocks melanosome transfer (a downstream step)

Layer 3 — Routine maintenance:

• Gentle cleanser, barrier-supportive moisturizer, no harsh exfoliation that could trigger PIH on top of the existing melasma

Timeline expectations

Melasma responds slower than most cosmetic concerns. Visible improvement at 8–12 weeks is the optimistic window per ^[G9]; meaningful change often takes 4–6 months of consistent multi-modal treatment. Discontinuation triggers rapid relapse — this is one of the few cosmetic concerns where stopping treatment immediately reverses the gains.

When to escalate to dermatology

• Severe or facial-spreading melasma
• No response after 4–6 months of consistent OTC treatment
• Hormone-related melasma during ongoing exposure (pregnancy, HRT, contraceptives) where the underlying driver isn't going away
• Significant skin-tone darkening risk that needs supervised treatment

Dermatology options:

• Hydroquinone 4% prescription form — strongest single-ingredient option, used in cycles to avoid ochronosis (paradoxical darkening from prolonged use)
• Kligman's trio (hydroquinone + tretinoin + corticosteroid) — combined topical regimen, 8–12 week courses
• Oral tranexamic acid — off-label for melasma; effective but requires medical supervision (clotting risk)
• In-office procedures — chemical peels (carefully selected for melasma — TCA peels can worsen it), laser (Q-switched, picosecond) only after pigment is stabilized, microneedling with depigmenting serums

Pregnancy-specific notes

Pregnancy melasma (chloasma / mask of pregnancy) often persists post-partum. During pregnancy, retinoids and hydroquinone are generally avoided ^[E1][E2]; focus on well-tolerated options like iron-oxide sunscreen, a vitamin C derivative, and azelaic acid. Topical tranexamic acid does not have established pregnancy safety data, so it is best left out unless your OB clears it. Because melasma is often hormone-driven and this touches pregnancy, run any active past your OB before you start or stop it — this is general information, not prenatal medical advice. Stronger treatment options can be revisited after weaning, with your dermatologist, if needed.

What doesn't help

• Aggressive AHA peels — risk triggering PIH on top of melasma
• 'Brightening' products without specific pigment-pathway actives
• Inconsistent sunscreen — without daily UV protection, every other treatment fights upstream
• Stopping treatment when pigmentation fades — relapse is rapid and the same routine has to be maintained

Bottom line

Melasma responds to multi-pathway treatment plus rigorous photoprotection. The OTC stack (iron-oxide sunscreen + vitamin C + tranexamic acid + azelaic acid + niacinamide) helps many cases over 4–6 months. For more stubborn or resistant melasma, dermatology offers stronger options. Drop's pigmentation-focused routine respects this layering.